0.2250
-0.0150
(-6.25%)
At close: January 10 at 11:46:41 AM EST
Breakdown
TTM
2/29/2024
2/28/2023
2/28/2022
2/28/2021
Operating Cash Flow
-2,731.5990
-2,294.9910
-863.9170
-2,999.5290
-1,623.6420
Investing Cash Flow
--
--
--
1,854.9830
-9.1240
Financing Cash Flow
2,599.8520
2,428.4630
856.5280
1,127.3620
1,648.9300
End Cash Position
71.6790
161.0590
27.5870
34.4420
70.2620
Interest Paid Supplemental Data
--
173.0020
82.9280
66.4140
142.5610
Capital Expenditure
--
--
--
-40.3560
-9.1240
Issuance of Capital Stock
1,963.6370
1,205.1410
151.8470
--
899.8430
Issuance of Debt
928.0870
2,258.3640
761.0450
--
1,100.0000
Repayment of Debt
-346.6690
-1,035.0420
-309.3640
-285.6540
-263.7630
Free Cash Flow
-2,731.5990
-2,294.9910
-863.9170
-3,039.8850
-1,632.7660
2/28/2021 - 2/10/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GTTX.CN GeneTether Therapeutics Inc.
0.1200
0.00%
NDTP NDT Pharmaceuticals Inc.
0.2080
0.00%
WBIO.CN WPD Pharmaceuticals Inc.
0.1900
0.00%
MRVL.V Marvel Biosciences Corp.
0.1550
0.00%
HMTXF Hemostemix Inc.
0.1670
+108.49%
DTC.CN Defence Therapeutics Inc.
0.6500
-1.52%
CHGX.CN ChitogenX Inc.
0.0250
+66.67%
APLI.TO Appili Therapeutics Inc.
0.0350
+16.67%
ICCC ImmuCell Corporation
5.19
+0.39%
BLAB.CN Britannia Life Sciences Inc.
0.0850
0.00%